Multi-parameter flow cytometry is a powerful analytical tool, enabling rapid measurement of multiple, physical and chemical characteristics of individual cells. Examples of clinical applications of flow cytometry analysis are the measurement of minimal residual disease (MRD) in leukemia, inflammatory disease and the effect of biologicals. While flow cytometry has become more advanced, the interpretation of information is still complicated and time consuming for clinicians, technicians and researchers. Radboud University Nijmegen, together with UMC Utrecht, has developed an algorithm able to process raw data and filter disease-specific outcomes, by comparing the patient data with a healthy population, making diagnosis easier and faster. Moreover, increased precision means the number of false negatives will be reduced, allowing for an early cancer intervention.
Recent news
INTRODUCING HEAT2MOVE: A NON-MEDICAL AND NON-INVASIVE PAIN RELIEVING TECHNOLOGY
PRESS RELEASE March 6, 2023 HEAT2MOVE, an NLC venture, sets out to provide a home care chronic pain relief option that is based on…
Read more
INTRODUCING ANSANA: A NEW STERILIZATION TECHNOLOGY FOR THE HEALTHCARE & PHARMACEUTICAL INDUSTRY.
PRESS RELEASE February 28, 2023 Ansana, an NLC venture, is on a mission to develop and launch a cutting-edge system for observing and confirming…
Read more
INTRODUCING CAREBED: A MOBILE-FRIENDLY SOLUTION FOR THE ELDERLY
PRESS RELEASE February 27, 2023 Carebed, an innovative bed that will increase a patient’s quality of life and reduce healthcare costs. Being dependent on…
Read more